Ginkgo Biloba extrait poudre en vrac

Qu’est-ce que la poudre d’extrait de Ginkgo Biloba?

La poudre d’extrait de Ginkgo biloba est une poudre fluide de jaune-brun clair extraite des feuilles séchées de Ginkgo biloba L., une plante de la famille des ginkgoacées, en utilisant des solvants appropriés, le principe actif. Ses principaux composants sont les flavonoïdes totaux de ginkgo, les ginkgolides, et d’autres substances, avec sont des vasodilatateurs, qui protègent le tissu endothélial des vaisseaux sanguins, la régulation des lipides sanguins, la protection des lipoprotéines de basse densité, l’inhibition du PAF (facteur d’activation des plaquettes), l’inhibition de la thrombose, le piégeage des radicaux libres, etc. Le 27 octobre 2017, l’organisation mondiale de la santé, le centre International de recherche sur le Cancer, a publié la compilation préliminaire de la liste des références cancérogènes, l’extrait de feuille de ginkgo biloba est dans la liste des cancérogènes du groupe 2B.

Poudre d’extrait de Ginkgo biloba En vrac Fourni par Green La technologie de ressort est strictement appliquée par des normes d’ue, et le processus de production entier est contrôlé et traçable des matières premières aux produits finis. Les tests de divers polluants sont effectués conformément aux normes les plus élevées de l’ue, et nous pouvons fournir des rapports d’essais faisant autorité par des tiers. Cette poudre d’extrait de Ginkgo biloba a une teneur élevée, une bonne solubilité dans l’eau et une qualité stable, et a été largement utilisée dans les produits de soins de santé, la nourriture, la médecine et d’autres domaines.

Spécification:

Règlement:

Il est conforme à la réglementation de l’ue.

Benefits:

Scavenging Free Radicals

Ginkgo biloba leaf extract can directly scavenge lipid radicals, lipid peroxidation radicals alkyl radicals, etc., and terminate the chain reaction chain of free radicals. It is also involved in regulating and enhancing the activity of antioxidant enzymes such as peroxide dismutase, glutathione peroxidase, etc. The antioxidant effect of flavonoids in ginkgo biloba extract even exceeds that of vitamins, and it has anti-free radical attack properties in vitro.

It has been demonstrated that the addition of different concentrations of ginkgo biloba leaf extract to different reaction systems can convert free radical products such as OH to non-free radical products. Ginkgo biloba extract scavenges in a manner similar to the antiradical effect of uric acid, and it also inhibits the free radicals produced by warming doxorubicin with liver microsomes P-450 and reduces the production of the lipid peroxide malondialdehyde (MDA). Since Ginkgo biloba extract is characterized by 2 components, hydrophilic and lipophilic, its therapeutic effect is superior to that of any single component.

Cardioprotection

Ginkgo biloba leaf extract has vasodilatory and cardioprotective effects and has significant therapeutic effects on cardiac ischaemia, allergic disorders, and infectious shock. In rabbit heart ischemia-reperfusion experiments, intracoronary injection of Ginkgo biloba extract can significantly inhibit the increase of MDA in plasma and myocardial tissue. The degree of damage to myocardial cells observed by electron microscopy was also significantly less than that of the control group. It also protected plasma tissue-type plasminogen activator (tPA) at a higher level and reduced PAI-1, an effect that may be beneficial by regulating fibrinolytic activity.

Protection Against Cerebral Ischaemia

The protective effect of Ginkgo biloba extract on cerebral ischaemia and cerebral oedema was observed in both the carotid artery ligation model and the rat cerebral oedema model of cerebral ischaemia and cerebral oedema. By maintaining the normal respiration of intracellular mitochondria, Ginkgo biloba prevented the disturbance of ion transport in the cell membrane caused by cerebral ischemia and prevented intracellular Ca2+ overload and brain cell damage. In cerebral infarction test, Ginkgo biloba extract can reduce the scope of focal cerebral infarction and improve the neurobehavioural disorders caused by ischemia. At the same time, Ginkgo biloba leaf extracts and Bilobalide had the effects of anti-ischemia-induced neuronal cell death and reduced mitochondrial gene expression.

Protection of Neurons

Flavonoids have a free radical scavenging effect and attenuate mitochondria-mediated apoptosis due to increased free radicals. Inhibit calcium ion in-flow, reduce amino acid excitability, and protect nerve cells from damage. Promotes ATP synthesis and reduces the production of inflammatory factors, thereby reducing neuronal effects. The active ingredients flavonoids in Ginkgo biloba extract inhibit the expression of mutated genes after ischaemia and reduce apoptosis.

Antithrombotic

Platelet-activating factor-PAF is the strongest aggregation factor and induces thrombosis. Ginkgolides, an extract of Ginkgo biloba, have been shown to be specific inhibitors of PAF and effective against thrombus formation. Against the phenomena of vasoconstriction and reduced blood flow after ischaemia-reperfusion. Ginkgo biloba leaf extract significantly reduces thrombosis caused by reperfusion and changes the rheology of blood.

Anti-inflammatory

Animal experiments have shown that low, medium, and high doses of Ginkgo biloba leaf extract injection can significantly reduce the concentration of serum ultrasensitive C-reactive protein (hs-CRP) in rats, suggesting that it can exert a certain inflammatory inhibitory effect. In addition, Ginkgo biloba extract injection can inhibit the stimulation of glial cells by lipopolysaccharide to a certain extent, reduce the production of tumour necrosis factor and interleukin-1b, and lower the level of inflammatory factor activity.

Applications:

In Pharmaceutical:

The modern application research and development of Ginkgo biloba began in Germany, the ginkgo biloba preparation "Tibonin" was developed in 1965 by the largest German botanical medicine enterprise, Dr. Weimar Schöppe Pharmaceuticals, and for the first time, a simple extract of Ginkgo biloba was registered, and a patent was filed for EGb761 in 1972, which was used for the treatment and prevention of Alzheimer's disease (dementia), terminal vascular blockage and other diseases. In 2001, the World Health Organisation (WHO) declared EGb761 to be the first choice for the treatment and prevention of cardiovascular and cerebrovascular diseases, making ginkgo biloba extract a globally-recognized killer of cardiovascular and cerebrovascular diseases.

For Health Products:

Ginkgo biloba extract can enhance human immunity, improve sleep quality, relieve fatigue, and so on. In addition, it can prevent and treat Alzheimer's disease, eye diseases, and other diseases. Ginkgo biloba extract powder has been widely used in health supplements, nutritional products, and other products.

For Feed Product:

In the field of veterinary medicine and feed, ginkgo biloba preparation is a kind of all-natural green feed additive, which is also widely used in livestock disease control. Ginkgo biloba extract has an immunomodulatory function, which can improve the anti-oxidative stress ability of livestock, and livestock away from the inhibition of pathogenic microorganisms, prevention of tumors, and no toxic side effects. In addition, Ginkgo biloba extract powder can improve the growth performance of broiler chickens, promote growth, and improve the feed conversion rate.